What is Discuva?
Discuva is a Cambridge, UK-based biotechnology firm dedicated to the discovery of novel antibiotics. Leveraging proprietary methods derived from recent advancements in genomic technologies, the company aims to develop targeted antibiotic therapies against emerging and drug-resistant pathogens. With an experienced management team from the pharmaceutical and biotech sectors and a strong scientific foundation, Discuva is positioned to tackle the growing global challenge of antimicrobial resistance.
How much funding has Discuva raised?
Discuva has raised a total of $1.9M across 1 funding round:
Grant
$1.9M
Grant (2017): $1.9M, investors not publicly disclosed
What's next for Discuva?
The recent major strategic investment signifies a pivotal moment for Discuva, likely enabling the company to accelerate its research and development pipeline, expand its operational capacity, and advance its lead antibiotic candidates towards clinical trials. This infusion of capital is expected to bolster its efforts in combating infectious diseases and establishing new treatment paradigms in a field with significant unmet needs.
See full Discuva company page
